ANGPTL3 may be associated with plaque calcification in patients with coronary artery disease (CAD), and ANGPTL3 measurement may guide physicians in estimating the severity of plaque calcification and in planning anti-atherosclerotic management.
Please login or create a FREE account to view this content
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.